-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
BriaCell Therapeutics Corp. quarterly and annual Net Income (Loss) Attributable to Parent history and change rate from 2021 to Q2 2025.
- BriaCell Therapeutics Corp. Net Income (Loss) Attributable to Parent for the quarter ending 31 Jul 2025 was $-8,091,370, a 566% decline year-over-year.
- BriaCell Therapeutics Corp. Net Income (Loss) Attributable to Parent for the twelve months ending 31 Jul 2025 was $-26,311,867, a 449% decline year-over-year.
- BriaCell Therapeutics Corp. annual Net Income (Loss) Attributable to Parent for 2025 was $-26,311,867, a 449% decline from 2024.
- BriaCell Therapeutics Corp. annual Net Income (Loss) Attributable to Parent for 2024 was $-4,791,466, a 76.4% increase from 2023.
- BriaCell Therapeutics Corp. annual Net Income (Loss) Attributable to Parent for 2023 was $-20,302,394, a 24.4% increase from 2022.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)